Jaideep Dudani is Vice President of Portfolio Strategy and Management at HI-Bio. He was most recently at Relay Therapeutics, a precision medicine company focused on oncology and rare genetic diseases, where he played a cross-functional role in R&D and strategy/BD. Previously, Jaideep worked at Vida Ventures, and was involved in several of the company’s investments, including Allogene, Asklepios BioPharmaceutical, Oyster Point Pharma, Pionyr Immunotherapeutics and the seeding of Kyverna Therapeutics.

Jaideep completed his PhD at MIT in Biological Engineering and holds a BS in Bioengineering from UCLA.